Mache dechanj, echanj stock jodi a
Stock quotes de 71229 konpayi nan tan reyèl.
Mache dechanj, echanj stock jodi a

Stock quotes

Stock quotes sou entènèt

Stock quotes istwa

Mache dechanj majiskil

Dividann Stock

Pwofi nan aksyon konpayi

Rapò finansye

Rating aksyon nan konpayi yo. Ki kote envesti lajan?

Protagonist Therapeutics, Inc. bouchon mache

Volim nan komès stock Protagonist Therapeutics, Inc. jodi a ak istwa a nan lèt majiskil nan Protagonist Therapeutics, Inc. Depi nan kòmansman an nan komès nan PTGX aksyon sou echanj la machandiz.
Add to widgets
Te ajoute nan widgets

Protagonist Therapeutics, Inc. lèt majiskil

Jodi a lèt majiskil sou mache a nan Protagonist Therapeutics, Inc. se 1 317 965 184 US dola.
-57 963 520 $ (-4.21%)
chanjman nan lèt majiskil depi yè

Protagonist Therapeutics, Inc. lèt majiskil, sa vle di kantite aksyon eksepsyonèl miltipliye pa pri a pataje, yo montre. Protagonist Therapeutics, Inc. lèt majiskil la kalkile baze sou komès sou echanj acha. Sa a se enfòmasyon referans sou majiskil Protagonist Therapeutics, Inc.. Protagonist Therapeutics, Inc. majiskil = 1 317 965 184 dola ameriken.

Protagonist Therapeutics, Inc. volim nan komès

Jodi a volim nan komès de aksyon Protagonist Therapeutics, Inc. montan 128 830 US dola.
-1 177 371 $ (-90.14%)
chanjman nan volim nan komès depi yè

Protagonist Therapeutics, Inc. komès komès jodi a = 128 830 dola ameriken. Protagonist Therapeutics, Inc. te fè kòmès sou echanj valè diferan. Protagonist Therapeutics, Inc. komès nan tan reyèl hands sou pi echanj valè stock, sit entènèt nou an montre volim komès la chak jou nan Protagonist Therapeutics, Inc.. Valè tout aksyon Protagonist Therapeutics, Inc. ki emèt (Protagonist Therapeutics, Inc. kap mache) tonbe nan $ -57 963 520.

Montre:
Pou

Protagonist Therapeutics, Inc. mache bouchon tablo

Protagonist Therapeutics, Inc. majiskil sou yon graf pa ane. Chanjman nan majiskil Protagonist Therapeutics, Inc. pou chak semèn se 0.69%. 0% - yon chanjman nan lèt majiskil sou mache Protagonist Therapeutics, Inc. chak mwa. Jodi a, Protagonist Therapeutics, Inc. majiskil egal a 1 317 965 184 dola ameriken.

Semèn Mwa 3 mwa Ane 3 zan

Protagonist Therapeutics, Inc. Istwa kapitalizasyon

Dat Kapitalizasyon
Kapitalizasyon (mache lèt majiskil) se valè sou mache a tout aksyon nan konpayi te fè kòmès sou echanj la machandiz. Mache lèt majiskil egal a pri de aksyon miltipliye pa kantite de aksyon eksepsyonèl.
04/05/2023 1 317 965 184 $
03/05/2023 1 375 928 704 $
02/05/2023 1 306 428 800 $
01/05/2023 1 325 280 896 $
28/04/2023 1 313 580 416 $
27/04/2023 1 294 892 416 $
26/04/2023 1 308 961 152 $

Protagonist Therapeutics, Inc. tablo volim

Semèn Mwa 3 mwa Ane 3 zan

Protagonist Therapeutics, Inc. done istwa volim

Dat Volim (24h)
Volim komèsyal de aksyon Protagonist Therapeutics, Inc. se kantite total tout tranzaksyon ak aksyon PTGX achte ak vann pandan dat la chwazi a.
04/05/2023 128 830 $
03/05/2023 1 306 201 $
02/05/2023 704 792 $
01/05/2023 701 288 $
28/04/2023 326 821 $
27/04/2023 130 124 $
26/04/2023 608 967 $

Sou 04/05/2023, Protagonist Therapeutics, Inc. lèt majiskil mache a te $ 1 317 965 184. Protagonist Therapeutics, Inc. lèt majiskil sou mache a se $ 1 375 928 704 nan 03/05/2023. Protagonist Therapeutics, Inc. majiskil nan 02/05/2023 egal a 1 306 428 800 dola ameriken. Protagonist Therapeutics, Inc. majiskil nan 01/05/2023 egal a 1 325 280 896 dola ameriken.

Protagonist Therapeutics, Inc. majiskil nan 28/04/2023 egal a 1 313 580 416 dola ameriken. 27/04/2023 Protagonist Therapeutics, Inc. lèt majiskil mache egal a 1 294 892 416 dola ameriken. Lèt majiskil sou mache Protagonist Therapeutics, Inc. nan 26/04/2023 montan pou 1 308 961 152 dola ameriken.

Lèt majiskil Protagonist Therapeutics, Inc. jodi a se 1 317 965 184 $. Kapitalizasyon sou mache a nan Protagonist Therapeutics, Inc. te chanje a -4.213% konpare ak yè. Volim komèsyal de aksyon PTGX nan Protagonist Therapeutics, Inc. nan dènye jou komès montan pou 128 830 $. Volim komèsyal de aksyon de Protagonist Therapeutics, Inc. chanje pou -90.137% konpare ak jou komès anvan an.

Pri a de aksyon Protagonist Therapeutics, Inc.

Finans Protagonist Therapeutics, Inc.